Cargando…

Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease

BACKGROUND : Nonalcoholic fatty liver disease (NAFLD) has been more and more often regarded as a serious disorder, because nonalcoholic steatohepatitis (NASH), a part of NAFLD, may progress to the end stage of liver disease. Though an advanced age, obesity, diabetes mellitus (DM) etc. being not infr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Kyung Sik, Lee, Yeong Seok, Park, Heo Won, Seo, Sang Hyuck, Jang, Byung Guk, Hwang, Jun Young, Cho, Kwang Bum, Hwang, Jae Seok, Ahn, Sung Hoon, Kang, Yu Na, Kim, Gap Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2004
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531555/ https://www.ncbi.nlm.nih.gov/pubmed/15053039 http://dx.doi.org/10.3904/kjim.2004.19.1.19

Ejemplares similares

Segmental Groove Pancreatitis: Report of One Case
por: Hwang, Jun Young, et al.
Publicado: (2003)

A novel role of CRTC2 in promoting nonalcoholic fatty liver disease
por: Han, Hye-Sook, et al.
Publicado: (2021)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
por: Cho, Hyo Jung, et al.
Publicado: (2019)

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
por: Ahn, Jem Ma, et al.
Publicado: (2016)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

Association between Serum Irisin Levels and Non-Alcoholic Fatty Liver Disease in Health Screen Examinees
por: Choi, Eun Sung, et al.
Publicado: (2014)

Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat
por: Song, Yi-Sun, et al.
Publicado: (2013)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
por: Ahn, Hwa Young, et al.
Publicado: (2018)

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease
por: Ma, Yuanqiang, et al.
Publicado: (2021)

Associations among the Degree of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, Degree of Obesity in Children, and Parental Obesity
por: Oh, Min-Su, et al.
Publicado: (2016)

Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women
por: Kim, Min Kyung, et al.
Publicado: (2015)

Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study
por: Lee, Min-Kyung, et al.
Publicado: (2015)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
por: Yoon, Sang Jun, et al.
Publicado: (2023)

Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment
por: Ju, Uk-Il, et al.
Publicado: (2020)

Clonazepam Treatment of Pathologic Childhood Aerophagia with Psychological Stresses
por: Hwang, Jin-Bok, et al.
Publicado: (2007)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure
por: Jang, Ju-hong, et al.
Publicado: (2022)

Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients
por: Kim, Yun Jung, et al.
Publicado: (2012)

Hepatocellular Carcinoma in the Elderly: Clinical Characteristics, Treatment, Survival Analysis in Korean Patients Older than 70 Years
por: Kim, Yun Jung, et al.
Publicado: (2012)

Shifting Prevalence of Gallbladder Polyps in Korea
por: Lee, Yoo Jin, et al.
Publicado: (2014)

Education for Ward Nurses Influences the Quality of Inpatient's Bowel Preparation for Colonoscopy
por: Lee, Yoo Jin, et al.
Publicado: (2015)

Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective
por: Kim, Ki Hyun, et al.
Publicado: (2022)

The Relationship between Normal Serum Uric Acid and Nonalcoholic Fatty Liver Disease
por: Hwang, In-Cheol, et al.
Publicado: (2011)

Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum
por: Lee, Na Young, et al.
Publicado: (2020)

Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease
por: Jung, Eun Sun, et al.
Publicado: (2016)

Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease?: a Cross-Sectional Study of the Healthy Population
por: Park, Danbee, et al.
Publicado: (2017)

Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice
por: Na, Jinhyuk, et al.
Publicado: (2019)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Han, Man-Hoon, et al.
Publicado: (2020)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

A Case of Nonalcoholic Steatohepatitis and Small Intestinal Bacterial Overgrowth with Peripheral Edema Caused by Intestinal Bypass Surgery and Relieved by Repair
por: Sung, Young Kyung, et al.
Publicado: (2012)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease
por: Ahn, Sang Bong, et al.
Publicado: (2019)

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Chronic Kidney Disease, Hemodynamic Instability, and Endoscopic High-Risk Appearance Are Associated with 30-Day Rebleeding in Patients with Non-Variceal Upper Gastrointestinal Bleeding
por: Lee, Yoo Jin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ejj4vi3mf9fnqntv694lh4dp0h